- Solid formulation of BNC210 better and faster administration than liquid formulation.
- Bionomics PTSD Phase 2b trial will start soon with a tablet formulation.
- BNC210 has previously shown benefit for Social Anxiety Disorder, but the speed of effect was not consistent with acute treatment. New tablet formulation enables acute treatment.
- Phase 2 trial being scoped out for use of BNC210 for acute treatment of Social Anxiety Disorder.
- Discussion about the synergy between Bionomics BNC210 and EmpathBio EMP-01 for PTSD treatment.
For further details see:
Bionomics Finds A Second Bow To Its Antianxiety Drug BNC210